With all the different messages and information about the COVID-19 vaccine, you may be wondering whether your little one ...

Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...

The federal government has cancelled a deal with vaccine maker Novavax to manufacture COVID-19 vaccine in Montreal, the company said in a filing with the U.S. securities regulator.

Moderna beat on fourth-quarter revenue but lost ... That includes $193 million in write-downs of unused doses of the Covid vaccine, among other costs. Research and development expenses dropped ...

Moderna reports larger-than-expected quarterly loss Revenue falls 66% but beats expectations FDA pauses norovirus vaccine trial after adverse event report Feb 14 (Reuters) - Moderna (MRNA.O ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 14 trades. If we consider the specifics of ...

MSD and partner Moderna have started a late-stage trial ... Patients in the study will receive a 1 mg dose of V940 via intramuscular (IM) injection or a matched placebo once every three weeks ...

Moderna has deployed over 750 GPTs across the company, including assistants for advanced analytics, image generation, and various other tasks. Among these is Dose ID GPT, which aids clinical ...